Cooperative Agreement NU17CE010215
Award Date 9/1/23
Completion Date 8/31/28
Dollars Obligated $50M
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
New York, USA
Similar Awards
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $1,445,752 Project Grant under the CFDA 93.279 Drug Use and Addiction Research Programs to New York University (NYU) to conduct a population-based data linkage study on opioid use disorder (OUD) care trajectories and outcomes following acute service utilization. The study aims to characterize real-world OUD treatment trajectories, understand how they differ across patient subgroups, and measure...
- This $1,589,148 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will be used to evaluate the impact of state-level policies that aim to facilitate the initiation of medication-based treatment for opioid use disorder (OUD) in emergency department (ED) settings. The key products and services to be delivered include: 1) Creating a longitudinal, publicly available database of state laws and policies...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $431,750 to Rutgers, The State University of New Jersey to conduct research on informing national overdose prevention and treatment strategies for high-risk adolescents. The key objectives of this 2-year project are to: 1) estimate the prevalence of adolescent nonfatal drug overdose and identify high-risk demographic and clinical subgroups,...
- This $3,000,000 Project Grant award from the Executive Office of the President Office of the National Drug Control Policy (ONDCP) supports the Research and Data Analysis federal grant program (CFDA 95.007). The grant funds nine organizations to deliver community-level intervention initiatives to combat drug overdoses from September 1, 2021 to August 31, 2022. The University of Baltimore receives $3 million to oversee the grant, with specific services delivered through eight sub-awards. These...
- The Alaska Department of Health, Division of Public Health was awarded a $6,999,999 Project Grant from the Bureau of Justice Assistance's Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838). The grant aims to expand and enhance overdose fatality reviews, support population-specific activities across Alaska's seven public health regions, and strengthen partnerships with first responders and corrections through naloxone distribution and post-overdose outreach. Key...
- This Project Grant award of $189,500 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to determine the extent of cardiovascular disease (CVD) among people with opioid use disorder (OUD) and explore ways to prevent CVD in this population. The key objectives are to: 1) examine the relationship between CVD and OUD using Transformed Medicaid Statistical Information System data, and 2) assess the impact of Medicaid Health Homes...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $4,154,586 Cooperative Agreement under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of California, San Diego (UCSD) on August 15, 2025. The "Responding to the Increase in Substance Use, HIV, HCV, and Overdose in New England" (RISE-NE) project will establish a cohort of 1,200 people who use drugs (PWUD) in Rhode Island, Massachusetts, and Vermont to...
- The New Mexico Health Care Authority, Behavioral Health Services Division, Office of Substance Abuse Prevention will implement the Substance Abuse and Mental Health Services Administration's (SAMHSA) Strategic Prevention Framework Partnerships for Success initiative in four high-overdose counties in New Mexico. The $4,000,000 project, funded under CFDA 93.243 (Substance Abuse and Mental Health Services Projects of Regional and National Significance), will address polysubstance misuse leading...
- The Cooperative Agreement award, titled "Preventing Overdose in Supportive Housing: Stepped Wedge Randomized Controlled Trial of a Multi-Sector, Upstream Intervention", is funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,746,930 award supports a multi-sector, community-partnered, stepped wedge randomized controlled trial to evaluate the impact of a technical assistance intervention designed to help...
- This $1,442,434 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to increase naloxone availability and use in high-risk public library settings to reduce opioid overdose mortality. The project has three key objectives: 1) Understand institutional barriers and facilitators to naloxone uptake in public libraries; 2) Establish a cohort to monitor drivers of naloxone uptake and overdose incidents in...